SCHEMBL3229750

SCHEMBL3229750

Nc1cc(Cl)cc(Cl)c1.O=S(=O)(Cl)Cl

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.72
TP53 P04637 1/20 0.72
TSHR P16473 2/20 0.44
ALDH1A1 P00352 4/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CA1 P00915 6/20 0.38
CA2 P00918 6/20 0.38
CA9 Q16790 4/20 0.38
THRB P10828 2/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
CASP1 P29466 1/20 0.37
RECQL P46063 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TPMT P51580 1/20 0.35
CA4 P22748 3/20 0.33
CA12 O43570 2/20 0.33
CA3 P07451 2/20 0.33
CA6 P23280 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL127074 0.85
1,3,5-Trichlorobenzene SCHEMBL4216819 0.85 TSHR (0.61) CYP3A4TP53TSHRALDH1A1CA1
Hydrochloric Acid SCHEMBL10975110 0.82 CYP3A4 (0.93) CYP3A4TP53TSHRALDH1A1THRB
Hydrochloric Acid SCHEMBL4371942 0.82 CYP3A4 (0.93) CYP3A4TP53TSHRALDH1A1THRB
Sulfuric Acid SCHEMBL8640162 0.81 CYP3A4 (0.60) CYP3A4TP53TSHRALDH1A1MEN1
SCHEMBL13905714 0.80 CYP3A4 (0.52) CYP3A4TP53TSHRALDH1A1MEN1
Nitrogen SCHEMBL28728934 0.79 CYP3A4 (0.87) CYP3A4TP53TSHRALDH1A1THRB
SCHEMBL221178 0.78
SCHEMBL2808682 0.77 CYP3A4 (0.55) CYP3A4TP53TSHRALDH1A1MEN1
Carbamic Acid SCHEMBL28139890 0.76 CYP3A4 (0.68) CYP3A4TP53TSHRALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048950-A1 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-02-25 US disclosed
EP-2136811-A1 GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF Boehringer Ingelheim International GmbH (DE) 2009-12-30 EP disclosed
WO-2008124745-A1 GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048950-A1 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof NR3C1, MC2R, NR3C2 CYP3A4 450/4885TP53 1065/4885TSHR 187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.